Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic coma--an unnecessary death].

C Berne1

  • 1Högskolelektor, Sektion för Endokrinologi, Akademiska Sjukhuset, Uppsala.

Nordisk Medicin
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Diabetic ketoacidosis (DKA) is a serious complication of insulin-dependent diabetes mellitus (IDDM) with a 5-10% mortality rate. Early detection and patient education are crucial for preventing DKA, especially in younger IDDM patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Organization of trauma management in French level-1 pediatric trauma centers: A cross-sectional survey.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

Effectiveness of screening for diabetes mellitus in dental health care.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

The role of obesity-related genetic loci in insulin sensitivity.

Diabetic medicine : a journal of the British Diabetic Association·2012
Same author

Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.

Human reproduction (Oxford, England)·2011
Same author

Plasma levels of glucagon like peptide-1 associate with diastolic function in elderly men.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same journal

[Nordisk Medicine 1929-1998. Thanks and farewell!].

Nordisk medicin·1999
Same journal

[Scientific fraud and misconduct--need for comprehensive terminology].

Nordisk medicin·1999
Same journal

[Labor-market for Scandinavian physicians in the year 2000--dearth or surplus?].

Nordisk medicin·1999
Same journal

[Internet in consultation--headed for trouble?].

Nordisk medicin·1999
Same journal

[Interpretation of questionnaires. An translation method problem].

Nordisk medicin·1999
Same journal

[Assessment of patients' health status--review of the literature and assessment methods].

Nordisk medicin·1999
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus Research

Context:

  • Diabetic ketoacidosis (DKA) is a life-threatening complication of insulin-dependent diabetes mellitus (IDDM).
  • Hospitalized DKA patients face a 5-10% mortality rate, with cardiovascular disease, infection, and adult respiratory distress syndrome (ARDS) as primary contributors.
  • Acidosis severity does not differentiate between survivors and non-survivors.

Purpose:

  • To highlight the significant mortality associated with DKA in IDDM patients.
  • To identify key factors contributing to DKA mortality.
  • To emphasize the increased risk and incidence of DKA in younger IDDM populations and discuss potential links to intensified insulin therapy.

Summary:

  • DKA significantly contributes to mortality in IDDM, particularly in younger age groups, where incidence is higher.

Related Experiment Videos

  • Factors like cardiovascular disease, infection, and ARDS are major causes of death in hospitalized DKA patients.
  • Intensified insulin regimens may increase the risk of insulin deficiency, necessitating improved patient education and ketonuria monitoring for DKA prevention and management.

    • Impact:

    • Underscores the critical need for enhanced patient and healthcare provider education regarding DKA prevention and management.
    • Suggests a re-evaluation of intensified insulin therapy protocols in IDDM to mitigate DKA risk.
    • Promotes early detection of ketonuria for timely intervention, aiming to reduce DKA-related morbidity and mortality.